Dechra Pharmaceuticals PLC
LSE:DPH
Dechra Pharmaceuticals PLC
Revenue
Dechra Pharmaceuticals PLC
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Dechra Pharmaceuticals PLC
LSE:DPH
|
Revenue
£761.5m
|
CAGR 3-Years
14%
|
CAGR 5-Years
13%
|
CAGR 10-Years
15%
|
|
GlaxoSmithKline PLC
LSE:GSK
|
Revenue
£30.7B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
0%
|
CAGR 10-Years
2%
|
|
AstraZeneca PLC
LSE:AZN
|
Revenue
$47.6B
|
CAGR 3-Years
20%
|
CAGR 5-Years
16%
|
CAGR 10-Years
6%
|
|
Verona Pharma PLC
NASDAQ:VRNA
|
Revenue
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Indivior PLC
LSE:INDV
|
Revenue
$1.1B
|
CAGR 3-Years
19%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
Revenue
$2.9B
|
CAGR 3-Years
7%
|
CAGR 5-Years
7%
|
CAGR 10-Years
8%
|
See Also
What is Dechra Pharmaceuticals PLC's Revenue?
Revenue
761.5m
GBP
Based on the financial report for Jun 30, 2023, Dechra Pharmaceuticals PLC's Revenue amounts to 761.5m GBP.
What is Dechra Pharmaceuticals PLC's Revenue growth rate?
Revenue CAGR 10Y
15%
Over the last year, the Revenue growth was 12%. The average annual Revenue growth rates for Dechra Pharmaceuticals PLC have been 14% over the past three years , 13% over the past five years , and 15% over the past ten years .